glp 1 agonist drugs for weight loss GLP-1 agonists are part of a new generation of medications designed to support and improve metabolic conditions. 🔬 How they work GLP-1 agonists mimic a natural hormone that helps regulate GLP-1 medications for weight loss

BMJ 379 , e071380 (2022)

GLP-1 Receptor Agonists for Type 2 Diabetes | UK Guide Glucagon-like peptide-1 receptor agonists for type 2 diabetes are a class of injectable and oral medicines that help manage blood glucose levels in adults

Based on the glucose sensing mechanism in GLP-1-producing cells [33-35], it is assumed that the subsequent depolarization of the K cell membrane potential activates voltage-dependent Ca 2+ channels (VDCCs), leading to an increase in intracellular Ca 2+ levels that facilitates vesicular exocytosis [29]

One of the more recent developments is the introduction of glucagon-like peptide-1 receptor agonists (GLP-1 RAs)

Common GLP-1 drugs include: Semaglutide (Ozempic, Wegovy, Rybelsus) Liraglutide (Victoza, Saxenda) Dulaglutide (Trulicity) Exenatide (Byetta, Bydureon) These drugs improve insulin resistance , aid in weight loss , and now appear to reduce inflammation , offering benefits far beyond diabetes

Risk ratios (RR) for the renal outcome estimates according to direct (DPP-4 inhibitors, GLP-1RA and SGLT-2 inhibitors against placebo) and indirect (DPP-4 inhibitors vs GLP-1RA or SGLT-2 inhibitors, and GLP-1RA vs SGLT-2 inhibitors) comparisons